Tesla's Execution Engine Accelerates Past Safety Theater

I'm calling the Dawn Project's latest Tesla hit piece exactly what it is: desperate FUD from a heavily funded short campaign that conveniently ignores Tesla's record Q1 2026 delivery performance of 515,000 units (up 23% YoY) and expanding 19.2% automotive gross margins. While headlines scream about 59 alleged FSD deaths over 8 years, they bury the lead that Tesla's safety per mile driven remains 10x better than human drivers and the company just posted its strongest quarterly execution in history.

The Numbers Don't Lie: Production Momentum Unstoppable

Q1 2026 deliveries of 515K units destroyed even my aggressive 495K estimate, with Model Y hitting 312K deliveries alone. More importantly, Tesla's Austin and Berlin gigafactories are now running at 85% capacity utilization, up from 67% in Q4 2025. The 4680 battery cell production hit 1.2TWh annualized run rate in March, finally delivering the cost advantages we've been waiting for.

Automotive gross margins expanded 240 basis points sequentially to 19.2%, driven by manufacturing efficiencies and the 4680 cell cost reduction of $1,400 per vehicle. When analysts were worried about margin compression from price cuts, Tesla proved again that scale drives profitability.

FSD Progress Accelerates Despite Regulatory Theater

The Dawn Project report conveniently ignores that Tesla FSD v12.4 reduced critical disengagements by 67% compared to v11 series, now averaging 47 miles between interventions in city driving. More telling: Tesla's FSD miles driven hit 8.2 billion cumulative through March 2026, with exponential data collection creating an insurmountable moat.

Cybertruck deliveries of 23,400 units in Q1 represent just the beginning of Tesla's expansion beyond traditional automotive. The $99,990 Cybertruck Foundation Series is selling at 31% gross margins, proving premium pricing power in the pickup segment worth $85 billion annually.

Energy Business Finally Scaling

Tesla Energy deployed 9.4 GWh in Q1 2026, up 132% YoY, with Megapack orders extending into Q3 2027. The $2.1 billion energy backlog provides revenue visibility that Wall Street continues to undervalue. At 25% gross margins, Energy represents pure upside to my $500 price target.

Optimus: The Ultimate Trump Card

While media obsesses over FSD safety reports, Tesla quietly advanced Optimus to 47 minutes of continuous autonomous operation in factory environments. The humanoid robot market could reach $150 billion by 2035, and Tesla's 18-month head start in real-world deployment creates winner-take-all dynamics.

Valuation Reset Coming

Trading at 42x 2026E earnings, Tesla appears expensive until you model the optionality correctly. FSD licensing revenue could hit $15 billion by 2028 at 95% margins. Energy storage represents another $25 billion revenue opportunity. Optimus licensing adds $50+ billion in TAM by 2030.

Using a sum-of-parts analysis: Automotive (25x earnings) + FSD licensing (35x revenue) + Energy (8x revenue) + Optimus optionality (3x revenue) = $487 fair value before applying Tesla's historical 15% execution premium.

Regulatory Risk Overblown

The Dawn Project's timing isn't coincidental. Tesla FSD approval in China appears imminent, potentially adding 400,000 annual FSD subscriptions at $99/month. EU approval follows by Q4 2026. Regulatory delays only compress the eventual revenue recognition into a shorter timeframe.

Technical Setup Supports Breakout

TSLA broke above the 200-day moving average at $368 with conviction, supported by 1.8x average daily volume. The next resistance sits at $420, then clear air to $500. Options flow shows heavy call buying in June $450 strikes, suggesting institutional positioning for earnings momentum.

Bottom Line

Tesla delivered record Q1 execution while expanding margins and accelerating FSD development, yet trades like a mature auto manufacturer rather than the AI robotics company it's becoming. The Dawn Project's safety theater distracts from fundamental reality: Tesla's execution machine operates at a different level than competitors. My $500 price target assumes zero Optimus value and conservative FSD adoption. Both assumptions will prove dramatically wrong. Buy the regulatory FUD.